机构：[1]Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China四川大学华西医院[2]West China School of medicine, West China Hospital, Sichuan University, China四川大学华西医院[3]Department of Rehabilitation, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, China
Luzhou City Science and
Technology Bureau (grant number 2021LZXNYDJ10 and
2020LZXNYDJ14), Science and Technology Department of Sichuan
Province (grant number 2021YJ0463 and 2021TFS0070).
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2023]版：
大类|3 区医学
小类|3 区外科
最新[2023]版：
大类|3 区医学
小类|3 区外科
第一作者：
第一作者机构：[1]Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China[2]West China School of medicine, West China Hospital, Sichuan University, China
共同第一作者：
通讯作者：
通讯机构：[3]Department of Rehabilitation, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, China[*1]Department of Rehabilitation, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, China.
推荐引用方式(GB/T 7714)：
Wang Jie,Xiao Yuhan,Li Dengxiong,et al.ZMYND10 could serve as a prognostic biomarker for patients with prostate cancer[J].Asian journal of surgery.2023,doi:10.1016/j.asjsur.2023.07.093.
APA：
Wang Jie,Xiao Yuhan,Li Dengxiong&Zhang Chi.(2023).ZMYND10 could serve as a prognostic biomarker for patients with prostate cancer.Asian journal of surgery,,
MLA：
Wang Jie,et al."ZMYND10 could serve as a prognostic biomarker for patients with prostate cancer".Asian journal of surgery .(2023)
